Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763919 · ClinicalTrials.gov registry record · NA
Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT00763919: Completed NA study, sponsored by Case Western Reserve University.
NCT00763919 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00763919, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
In this study, patients with bipolar disorder who do not take their medications as prescribed will receive specialized education and therapy treatment to determine whether the specialized treatment is effective in helping patients to take their medications consistently.
Primary Outcome
The minimum score is 0 and the maximum score is 100. A higher score implies poorer treatment adherence.
Interventions
- BEHAVIORAL Psychoeducation module
- BEHAVIORAL Improved communication/rapport with provider module
- BEHAVIORAL Medication routines management module
- BEHAVIORAL Substance abuse module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00763919 record still lists
NCT00763919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Psychoeducation module is the first listed.
NCT00763919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00763919 about?
NCT00763919 is a clinical study titled "Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder". In this study, patients with bipolar disorder who do not take their medications as prescribed will receive specialized education and therapy treatment to determine whether the specialized treatment is effective in helping patients to take their medications consistently.
What is the current status of trial NCT00763919?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2008-07. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00763919?
The interventions under investigation include: Psychoeducation module (BEHAVIORAL), Improved communication/rapport with provider module (BEHAVIORAL), Medication routines management module (BEHAVIORAL), Substance abuse module (BEHAVIORAL).
Who is sponsoring clinical trial NCT00763919?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00763919's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia